Culturing the Human Natural Killer Cell Line NK-92 in Interleukin-2 and Interleukin-15 - Implications for Clinical Trials

Tutkimustuotos: Lehtiartikkeli › Artikkeli › Tieteellinen › vertaisarvioitu

34 Sitaatiot (Scopus)

Alkuperäiskieli	Ei tiedossa
Sivut	107–112
Julkaisu	Anticancer Research
Vuosikerta	39
Numero	1
DOI - pysyväislinkit	https://doi.org/10.21873/anticanres.13085
Tila	Julkaistu - 2019
OKM-julkaisutyyppi	A1 Julkaistu artikkeli, soviteltu

Pääsy asiakirjaan

@article{798431bf938e44448a7c3db71298372d,

title = "Culturing the Human Natural Killer Cell Line NK-92 in Interleukin-2 and Interleukin-15 - Implications for Clinical Trials",

author = "HEIDI T{\"O}RNROOS and Henry H{\"a}gerstrand and Christer Lindqvist",

note = "ej bett om fulltext 5.8.20 J{\"O}",

year = "2019",

doi = "10.21873/anticanres.13085",

language = "Odefinierat/ok{\"a}nt",

volume = "39",

pages = "107–112",

journal = "Anticancer Research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

number = "1",

}

TY - JOUR

T1 - Culturing the Human Natural Killer Cell Line NK-92 in Interleukin-2 and Interleukin-15 - Implications for Clinical Trials

AU - TÖRNROOS, HEIDI

AU - Hägerstrand, Henry

AU - Lindqvist, Christer

N1 - ej bett om fulltext 5.8.20 JÖ

PY - 2019

Y1 - 2019

U2 - 10.21873/anticanres.13085

DO - 10.21873/anticanres.13085

M3 - Artikel

SN - 0250-7005

VL - 39

SP - 107

EP - 112

JO - Anticancer Research

JF - Anticancer Research

IS - 1

ER -